Prieya Pavana Wason
About Prieya Pavana Wason
Prieya Pavana Wason serves as the Director of Clinical Operations at Nektar Therapeutics, bringing extensive experience from various roles in clinical research and operations across multiple organizations.
Current Role at Nektar Therapeutics
Prieya Pavana Wason serves as the Director of Clinical Operations at Nektar Therapeutics. She has held this position since 2018, contributing to the company's clinical development efforts in South San Francisco, California. In this role, she oversees clinical operations, ensuring that clinical trials are conducted efficiently and in compliance with regulatory standards.
Previous Experience in Clinical Operations
Prior to her current role, Wason accumulated extensive experience in clinical operations across various organizations. She worked as the Director of Clinical Operations at Aduro Biotech from 2017 to 2018 and served as Associate Director of Clinical Operations at the same company from 2015 to 2017. Her experience also includes roles at Verily Life Sciences and Actelion, where she held positions such as Senior Clinical Operations Specialist and Senior Clinical Program Manager, respectively.
Education and Academic Background
Wason studied at the University of California, Davis, where she earned a Bachelor of Science degree from 1993 to 1998. She furthered her education at the University of California, Santa Cruz, focusing on Management and Design from 2001 to 2003. This educational background provides her with a strong foundation in both scientific and management principles.
Career Progression in Clinical Research
Wason's career in clinical research began at Microgenics, where she worked as a Chemist I, II, III, and Project Leader from 1998 to 2002. She then transitioned to various roles in clinical operations, including positions at Johnson & Johnson and PDL Biopharma. Her experience spans over two decades, showcasing her growth and expertise in the clinical research field.
Consulting Experience
Wason has also worked as a Clinical Consultant at Intermune from 2013 to 2015. Additionally, she served as a Senior CRA Consultant at Advanced Clinical Research Services for one year in Illinois. These consulting roles have allowed her to provide expert guidance in clinical operations and enhance her understanding of the industry.